From the authors of this study. If you read this article further...

From the authors of this study. If you read this article further you see it's tamiflu that needs to be worried.

"Patients who receive the recommended dosages of oseltamivir and zanamivir would easily have high enough systemic levels of the drugs to still be effective against the S247N variant, "and therefore the variant is unlikely to be clinically resistant," the report states."


http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/jun1011resist.html